ALDX - Aldeyra Therapeutics Inc Stock Price, Fair Value and News

$4.72-0.04 (-0.84%)

Delayed as of 21 Nov 2024, 09:54 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ALDX Price Action

Last 7 days

7.9%

Last 30 days

-13.9%

Last 90 days

-9.0%

Trailing 12 Months

95.1%

ALDX RSI Chart

ALDX Valuation

Market Cap

283.5M

Price/Earnings (Trailing)

-6.33

EV/EBITDA

-4.76

Price/Free Cashflow

-9.24

MarketCap/EBT

-5.49

ALDX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ALDX Fundamentals

ALDX Earnings

Earnings (TTM)

-44.8M

Earnings Growth (Yr)

-84.6%

Earnings Growth (Qtr)

10.3%

ALDX Profitability

Return on Equity

-52.64%

Return on Assets

-38.18%

Free Cashflow Yield

-10.82%

ALDX Investor Care

Shares Dilution (1Y)

1.24%

Diluted EPS (TTM)

-0.75

Revenue & Growth

About Aldeyra Therapeutics Inc

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases. The company also develops ADX-629, an orally administered RASP modulator for treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment primary vitreoretinal lymphoma cancer, proliferative vitreoretinopathy, and retinitis pigmentosa, as well as rare retinal diseases characterized by inflammation and vision loss. In addition, it develops ADX-246 in systemic immune-mediated disease; and ADX-248 in geographic atrophy. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

CEO	Dr. Todd C. Brady M.D., Ph.D.
WEBSITE	aldeyra.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	15

Aldeyra Therapeutics Inc Frequently Asked Questions

What is the ticker symbol for Aldeyra Therapeutics Inc? What does ALDX stand for in stocks?

ALDX is the stock ticker symbol of Aldeyra Therapeutics Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Aldeyra Therapeutics Inc (ALDX)?

As of Wed Nov 20 2024, market cap of Aldeyra Therapeutics Inc is 283.46 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ALDX stock?

You can check ALDX's fair value in chart for subscribers.

Is Aldeyra Therapeutics Inc a good stock to buy?

The fair value guage provides a quick view whether ALDX is over valued or under valued. Whether Aldeyra Therapeutics Inc is cheap or expensive depends on the assumptions which impact Aldeyra Therapeutics Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ALDX.

What is 5 year return on Aldeyra Therapeutics Inc's stock?

In the past 10 years, Aldeyra Therapeutics Inc has provided -0.045 (multiply by 100 for percentage) rate of return.